Ziphius Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $16.1M

  • Investors
  • 3

Ziphius General Information

Description

Developer of a global biopharmaceutical platform designed to offer vaccines for the prevention of infectious diseases. The company's platform acts as an antigen and initiates a defense mechanism in the body, focusses on self-amplifying RNA-based vaccines for a variety of infectious diseases and protein replacement therapies to rapidly expand the pipeline and move forward multiple preclinical development programs towards the clinic, enabling healthcare providers to reduce the global impact of infectious diseases on global health care.

Contact Information

Website
www.ziphius.org
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Heidestraat 19
  • 9820 Merelbeke
  • Belgium
+32 050
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Heidestraat 19
  • 9820 Merelbeke
  • Belgium
+32 050

Ziphius Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ziphius Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 24-Dec-2024 $16.1M Completed Generating Revenue
1. Early Stage VC (Series A) 22-May-2021 Completed Pre-Clinical Trials
To view Ziphius’s complete valuation and funding history, request access »

Ziphius Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Ordinary
Ordinary 15,980 $325.97 $325.97 0x $325.97 5.06%
Ordinary 78,200 $325.97 $325.97 0x $325.97 24.74%
To view Ziphius’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Ziphius Patents

  • 8

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 8

    Pending

  • Expiring in next 12 mo

Ziphius Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4426271-A1 Lipid nanoparticles for oligonucleotide delivery Pending 02-Nov-2021
JP-2024540101-A Lipid nanoparticles for oligonucleotide delivery Pending 02-Nov-2021
JP-2024540108-A Lipid nanoparticles for oligonucleotide delivery Pending 02-Nov-2021
AU-2021291231-A1 Self-amplifying sars-cov-2 rna vaccine Pending 19-Jun-2020
CA-3187290-A1 Self-amplifying sars-cov-2 rna vaccine Pending 19-Jun-2020 C07K14/005
To view Ziphius’s complete patent history, request access »

Ziphius Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ziphius Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Annie Vereecken Angel (individual) Minority
Christian Dumolin Angel (individual) Minority
Jan Haspeslagh Angel (individual) Minority
To view Ziphius’s complete investors history, request access »

Ready to get started?

Request a free trial

Ziphius FAQs

  • When was Ziphius founded?

    Ziphius was founded in 2019.

  • Where is Ziphius headquartered?

    Ziphius is headquartered in Merelbeke, Belgium.

  • What is the size of Ziphius?

    Ziphius has 60 total employees.

  • What industry is Ziphius in?

    Ziphius’s primary industry is Drug Discovery.

  • Is Ziphius a private or public company?

    Ziphius is a Private company.

  • What is the current valuation of Ziphius?

    The current valuation of Ziphius is .

  • What is Ziphius’s current revenue?

    The current revenue for Ziphius is .

  • How much funding has Ziphius raised over time?

    Ziphius has raised $51.6M.

  • Who are Ziphius’s investors?

    Annie Vereecken, Christian Dumolin, and Jan Haspeslagh have invested in Ziphius.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »